Navigation Links
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Europe Diabetes Care Devices market..

- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, LifeScan, Inc., Medtronic, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Europe Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Diabetes Care Devices in Europe 12

3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 12

3.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13

3.3 Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17

3.4 Diabetes Care Devices, Europe, Company share (2009-2010) 20

4 Diabetes Care Devices In Germany 22

4.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22

4.2 Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27

4.3 Diabetes Care Devices, Germany, Distribution Share (2009-2010) 30

4.3.1 Glucos

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
8. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
11. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Post Your Comments:
(Date:10/8/2015)... 8, 2015 " Biomedical Refrigerators ... Trends and Forecast 2014 - 2022 " , the ... billion in 2013 and is anticipated to expand at a ... 4.00 billion in 2022. --> " Biomedical ... Growth, Trends and Forecast 2014 - 2022 " , ...
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
(Date:10/8/2015)... -- Celtaxsys, a clinical stage drug development company focused on ... announced today the commencement of the US arm of ... compound, acebilustat, in patients with cystic fibrosis (CF). The ... the United States and European ... early 2016. This landmark clinical trial testing once-daily oral ...
Breaking Medicine Technology:
... July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... results for the second quarter 2011 prior to the open ... John H. Johnson, Chief Executive Officer and President, and ... host an investment community conference call beginning at 9:00 a.m. ...
... LOUISVILLE, Ky., July 20, 2011 BellaNovus Development ... today announced its launch of the Ouchless™ Needle ... an innovative alternative to numbing creams and ice ... cosmetic injectables, such as Botox® and dermal fillers. ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... upcoming episode of Innovations with Ed Begley Jr., airing 1st QT 2016 via ... will educate audiences on MMJ Phytotech Limited (MMJ) – a global leader in ...
(Date:10/9/2015)... Bethesda, Maryland (PRWEB) , ... October 09, 2015 ... ... care and assisted living placement counseling, recently opened its newest office in Maryland ... the senior care industry with a background as a project management technology consultant ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Kitchenistas of National ... diabetes, obesity, and other health conditions related to food, has been selected for viewing ... at the Global Health Film Festival on October 30-31 in London, England. , The ...
(Date:10/9/2015)... Abilene, Texas (PRWEB) , ... October 09, 2015 , ... ... new article this week that takes the subject of health care back to the ... too many sicknesses that are able to be prevented if only biblical laws were ...
(Date:10/8/2015)... ... October 09, 2015 , ... The Guthrie Sports Medicine/Twin Tiers ... support post-concussion group was started by Steven Hicks, a Licensed Athletic Trainer, with ... was started in November 2010 to help support student athletes, their ...
Breaking Medicine News(10 mins):
... may be related to trend toward less sleep, ... to the many reasons why people should get adequate sleep, ... insulin resistance, a component of type 2 diabetes. , The ... after a night of normal sleep (about eight hours) and ...
... In ... Trade to the table with Tampa Bay’s greenest coffee roasters. , ... Tampa, Fla. (PRWEB) May 6, 2010 -- Java Planet, ... and commitment to Fair Trade by gaining the certifications needed to be able to use ...
... anatomical alterations in children with genetic disorder , THURSDAY, May ... with fragile X syndrome differs from that in boys without ... X syndrome, which is triggered by a mutation in a ... inherited intellectual disability and autism. Though the syndrome affects ...
... is safe, improves blood sugar control , THURSDAY, May ... have been encapsulated have been successfully transplanted into humans ... cells. , What,s more, scientists report, the transplanted pig ... to high blood sugar levels in the blood, improving ...
... releases (embargo: 6 May, 16:45 CEST) , J. Hicks, ... cells from very small samples , Researchers have developed a ... cells. The breakthrough allows them to study in fine detail ... Estrogen receptor status of HER2+ breast cancer correlates with response ...
... Brussels, 6 May 2010 -- An international team of ... some women with HER2 over-expressing breast cancer do not ... The research, presented at the IMPAKT Breast Cancer ... on future clinical trial design and treatment strategies in ...
Cached Medicine News:
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
... profile endocardial permanent pacing leads with an ... size of only 4.8 F and a ... Physique lead is the smallest extendable/retractable bipolar ... straight and pre-formed J configurations, Physique leads ...
... The Vitatron Impulse II lead series ... designed to extend the longevity of ... efficient pacing. The high impedance of ... the small electrode surface, combined with ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
Medicine Products: